ATYR
aTyr Pharma Inc
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-3.70%
Annual Growth
5 years average annual growth
🌏
2
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodulator in clinical development for the treatment of interstitial lung disease (ILD), a group of immune-mediated disorders that can cause inflammation and fibrosis, or scarring, of the lungs. Efzofitimod is a tRNA synthetase derived therapy that selectively modulates activated myeloid cells through neuropilin-2 (NRP2) to resolve aberrant inflammation without immune suppression and prevent the progression of fibrosis. ATYR0101 is a fusion protein derived from a domain of aspartyl-tRNA synthetase (DARS). ATYR0101 binds directly to latent-transforming growth factor beta-binding protein 1 (LTBP1), which regulates transforming growth factor beta (TGFb). Its ATYR0750 is a fusion protein derived from a domain of alanyl-tRNA synthetase (AARS).
📈 Performance
Price History*
-98.40%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$3.35
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ATYR
2
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
13 weeks
💵 Average investment amount
$394
⏰ Last time a customer invested in ATYR
10 days
ATYR investor breakdown
💵 Income of investors
More than 200k
50%
150k - 200k
100k - 150k
50k - 100k
Less than 50k
50%
👶 Age of investors
18 - 25
50%
26 - 34
35 - 90
50%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in ATYR also invest in...
🙌 Performance (5Yr p.a)
430.24%
📊 Share price
$134.70 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
33.99%
📊 Share price
$119.21 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...